Increased proportions of HIV-infected women met cervical cancer screening guideline in 2016
Authors Mohammed DY, Shukla P, Babayants Y, Sison R, Slim J
Received 1 October 2017
Accepted for publication 22 November 2017
Published 16 February 2018 Volume 2018:10 Pages 83—87
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Colin Mak
Peer reviewer comments 3
Editor who approved publication: Dr Everett Magann
Debbie Y Mohammed,1,2 Prerak Shukla,2 Yuriy Babayants,3 Raymund Sison,2 Jihad Slim2
1Department of Nursing, College of Science and Health, William Paterson University, Wayne, NJ, 2Division of Infectious Disease, Department of Medicine, Saint Michael’s Medical Center, Newark, NJ, 3School of Osteopathic Medicine, Rowan University, Stratford, NJ, USA
Background: HIV-infected women are five times more likely to develop invasive cervical cancer. Routine screening can detect early signs of cancer and provide an opportunity for treatment. However, suboptimal screening rates are reported in this population. This retrospective study examined the rates of cervical cancer screening in HIV-positive women, conducted according to the current guidelines, from 2014 to 2016 in an inner-city clinic.
Materials and methods: We implemented focused scheduling for eligible women by a designated medical assistant. Testing was conducted using Thin Prep™ and Cervista HPV HR™. Chi-square tests and logistic regression models were used to assess predictors of cervical cancer screening in 2016.
Results: A total of 360 adult HIV-infected women were active in medical care, as of December 31, 2016. Most were African American (77%) and aged 51–60 years (38%). In 2016, 75% of women met the guidelines for cervical cancer screening, compared to 48% in 2014. There was a significant association between receipt of cervical cancer screening in the prior 3 years and screening in 2016. In an adjusted model, those with a prior screening were 6.88 times (95% CI, 3.47–13.67) more likely to be screened in 2016, compared to those who were never previously screened.
Conclusion: Focused scheduling and implementation of the updated cervical cancer screening guideline extending the period of rescreening, after 3 yearly negative results or negative Papanicolaou/human papilloma virus testing, resulted in an increased proportion of women meeting the current guideline.
Keywords: cervical cancer screening guidelines 2015, HIV-infected women, Pap smear, HPV
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]